Bazedoxifene

Also known as: 1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-indol-5-ol, 1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol, 1-{4-[2-(1-Azepanyl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol, 1-{4-[2-(Azepan-1-yl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol, 1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-, 1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, Bazedoxifeno, Conbriza, TSE-424

Bazedoxifene (CAS 198481-32-2) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C30H34N2O3 and a molecular weight of 470.603 g/mol. Key properties include a boiling point of 694.4±55.0 °C at 760 mmHg, a density of 1.2±0.1 g/cm3 and a flash point of 373.8±31.5 °C. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 198481-32-2
Jingsj CID: J-1971975-6
Molecular Formula: C₃₀H₃₄N₂O₃
Molecular Weight: 470.603 g/mol
Category: Organic Compounds
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Boiling Point	694.4±55.0 °C at 760 mmHg
Density	1.2±0.1 g/cm3
Flash Point	373.8±31.5 °C
Exact Mass	470.256958
PSA	57.86000
LogP	6.59
Vapor Pressure	0.0±2.3 mmHg at 25°C
Refractive Index	1.622
Storage Conditions	2-8℃

Activity & Biological Data

Additional Information	[1]. Lewis-Wambi JS, et al. The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1. Mol Pharmacol. 2011 Oct;80(4):610-20. [2]. Duggan ST, McKeage K. Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis. Drugs. 2011 Nov 12;71(16):2193-212. [3]. Lello S, Brandi ML, Minisola G et al. Bazedoxifene: literature data and clinical evidence. Clin Cases Miner Bone Metab. 2011 Sep;8(3):29-32. [4]. Komm BS, Chines AA. Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis. 2012 Feb;4(1):21-34.

Additional Information

[1]. Lewis-Wambi JS, et al. The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1. Mol Pharmacol. 2011 Oct;80(4):610-20. [2]. Duggan ST, McKeage K. Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis. Drugs. 2011 Nov 12;71(16):2193-212. [3]. Lello S, Brandi ML, Minisola G et al. Bazedoxifene: literature data and clinical evidence. Clin Cases Miner Bone Metab. 2011 Sep;8(3):29-32. [4]. Komm BS, Chines AA. Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis. 2012 Feb;4(1):21-34.

Frequently Asked Questions

What is the CAS number of Bazedoxifene?

The CAS number of Bazedoxifene is 198481-32-2.

What are the molecular formula and molecular weight of Bazedoxifene?

Bazedoxifene has molecular formula C30H34N2O3 and molecular weight 470.603 g/mol.

What are the upstream and downstream products of Bazedoxifene?

For Bazedoxifene, Upstream Products: 1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole, Adipaldehyde, Hexamethyleneimine.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Bazedoxifene (CAS 198481-32-2)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1971975-6 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.